Region — United States. Journal — evidence, plainly.
Cart · 0
Set region
Journal  /  Kojic acid vs arbutin
journal · ~9 min · updated 2026-07-22

Kojic Acid vs Arbutin: Same Target, Very Different Ingredients

Kojic acid and arbutin get shelved together as the "gentle, natural brightener" alternatives — the botanical, fermentation-derived options you reach for instead of harsher lightening agents. Both fade dark spots, both are plant- or fungus-derived, both aim at the same place in skin. So people treat them as roughly interchangeable and pick whichever the serum they like happens to contain.

But "aims at the same place" is doing a lot of quiet work in that sentence. They do target the same enzyme — the one that controls pigment production. Where they part ways isn't the target; it's everything around it: how gently they behave, how stable they are in the bottle, and how much of their reputation survives contact with real-world caveats. Follow those, and two ingredients that look like siblings turn out to earn genuinely different grades on the evidence.

Same target: both aim at the pigment enzyme

Start with what they share, because it's real and it's the source of the confusion.

Pigment production hinges on a single rate-setting enzyme (tyrosinase), which depends on copper to work. Both kojic acid and arbutin interfere with that enzyme rather than bleaching pigment that already exists — a "slow the production line" approach rather than a "scrub out the stain" one. Kojic acid works by grabbing the copper the enzyme needs; arbutin, structurally, occupies the enzyme's working site. Different chemistry, same destination: less new pigment made, so existing spots fade gradually and new ones form more slowly.

This shared mechanism is why they're constantly compared, and why they're so often combined rather than chosen between — hitting the same target two ways. But shared mechanism is where the similarity ends. On everything that determines whether an ingredient actually works well for you, they diverge sharply.

Where they split: gentleness, stability, and how much survives the caveats

Here's the part the "both gentle, both natural" framing flattens.

Arbutin is the stable, well-behaved one. It's mild, well tolerated across skin types including sensitive skin, chemically stable in a formula, and — as covered in arbutin vs hydroquinone — it earns a solid grade as a gentle, gradual brightener with a wide safety margin. Its whole appeal is that it works quietly and doesn't cause trouble. The trade is that it's gentle: gradual results, modest ceiling.

Kojic acid is the stronger-but-thornier one. In the lab, it's genuinely impressive — one of the most consistent pigment-enzyme inhibitors in comparative testing, with a mechanism that's arguably more potent than arbutin's on paper. But its caveats stack higher than any other brightener's, and honesty means naming all of them:

  • It's the brightener most associated with allergic contact dermatitis. Of the gentle-brightener set, kojic acid is the one most likely to provoke a reaction — an odd position for something sold on being "gentle."
  • It's chemically unstable. Kojic acid oxidises and loses potency, which is why it needs opaque, air-tight packaging to work at all by the time you use it.
  • It's photosensitising, making daily sunscreen even more non-negotiable than usual.
  • The regulated strength is milder than the studied strength. In the EU, kojic acid is capped at 1% (Regulation 2024/996) — but most of its efficacy evidence comes from 2–4%. So an EU-compliant product is deliberately weaker than what the studies that built its reputation actually tested.

Put those together and you see why the register grades them differently: arbutin sits a notch higher not because its lab mechanism is stronger — it isn't — but because far more of its promise survives contact with reality. Kojic acid's mechanism is the more impressive; kojic acid the finished cosmetic is the more compromised.

The twist: "stronger in the lab" is not "better on your face"

This is the trap the comparison sets, and it's worth stating plainly. On raw enzyme-inhibiting potency in a test tube, kojic acid arguably beats arbutin. If that were the whole story, kojic acid would win.

But a lab result is not a face. What reaches your skin is a formulated, regulated, shelf-aged product — and that's exactly where kojic acid's advantages erode. Capped to a milder strength than it was studied at, degrading in the bottle, more likely to irritate, and demanding careful packaging just to stay effective. Arbutin, meanwhile, gives up some theoretical potency and gets back stability, tolerability, and a wider margin for error — the things that actually determine whether you keep using an ingredient long enough for it to work. For a slow process like fading pigment, "gentle enough to use consistently for months" beats "stronger in a beaker" more often than not.

That's the honest resolution: kojic acid has the more powerful mechanism, arbutin the more reliable real-world profile — and pigment-fading rewards reliability.

Which one for you?

Your situationBetter pickWhy
Sensitive or reactive skinArbutinLower irritation and allergy risk
Want a stable, low-maintenance activeArbutinDoesn't degrade the way kojic acid does
Long-term, everyday tone maintenanceArbutinGentle and dependable over months
Want the stronger enzyme mechanismKojic acidMore potent inhibitor in lab terms
Already using a well-packaged combination serumEither / bothThey're often paired to hit the target two ways
Prone to contact allergiesArbutinKojic acid is the higher-sensitisation option

Our assessment: for most people — especially with sensitive skin or a preference for something dependable — arbutin is the more sensible everyday brightener, because more of its benefit actually reaches your skin. Kojic acid is a legitimate, well-established ingredient with a strong mechanism, but it's the most caveated of the pigment set, and it tends to perform best within a well-formulated combination rather than as a standalone hero. Many good brightening serums simply use both.

The honest picture

Neither is a scam and neither is a miracle — they're two takes on the same idea with different risk profiles. Arbutin is the gentle, stable, well-tolerated brightener whose modest promise mostly survives real-world use — a dependable everyday choice, graded solidly. Kojic acid has arguably the stronger pigment-enzyme mechanism, but sits lower on the evidence because its caveats pile up: the highest allergy risk of the brighteners, chemical instability, photosensitivity, and an EU-regulated strength milder than the studies that made its name. One is quietly reliable; the other is powerful on paper but high-maintenance in practice.

The real takeaway is that "same mechanism" didn't make them the same ingredient — tolerability, stability, and regulation matter as much as the target. And whichever you choose, the ingredient is the smaller half of the job: pigment fades slowly, comes back easily, and daily broad-spectrum sunscreen does more of the work than either brightener. Persistent or hormonal pigmentation like melasma is a dermatologist's territory, not a serum's.

In the Registry

Related comparisons

Part of the ingredient comparison series.

Frequently asked questions

What's the difference between kojic acid and arbutin? They target the same pigment-making enzyme but behave very differently as ingredients. Both slow the production of new melanin rather than bleaching existing pigment — kojic acid by grabbing the copper the enzyme needs, arbutin by occupying the enzyme's working site. The real difference is everything around the mechanism: arbutin is mild, chemically stable, and well tolerated, so it's a dependable gentle brightener; kojic acid has an arguably stronger mechanism but is the brightener most associated with allergic reactions, is chemically unstable (it degrades in the bottle), is photosensitising, and is capped at a milder strength in the EU than most of its studies used. So arbutin is the reliable everyday option, while kojic acid is more powerful on paper but higher-maintenance in practice.

Which is better for hyperpigmentation, kojic acid or arbutin? For most people, arbutin is the more practical choice, because more of its benefit survives real-world use — it's stable, gentle, and easy to keep using consistently, which matters a lot for a slow process like fading pigment. Kojic acid has a strong pigment-enzyme mechanism and real evidence, but its instability, higher irritation and allergy risk, and EU strength cap mean the finished product often delivers less than its lab potential suggests. That said, they're frequently combined rather than chosen between, since hitting the same enzyme two ways can be more effective than either alone. For sensitive skin, arbutin is clearly the safer starting point; for stubborn pigmentation, a well-formulated combination (often including both, plus niacinamide or vitamin C) tends to outperform any single ingredient.

Is kojic acid or arbutin gentler on skin? Arbutin is clearly the gentler of the two. It's well tolerated across skin types, including sensitive skin, with a low irritation profile. Kojic acid, despite being marketed within the "gentle brightener" category, is actually the brightener most associated with allergic contact dermatitis, and it's also photosensitising — so it carries more risk of irritation and reactions than arbutin does. If your skin is sensitive or reactive, or you've had contact allergies before, arbutin is the safer choice. With kojic acid, patch-testing and diligent daily sunscreen matter even more than usual.

Can you use kojic acid and arbutin together? Yes, and this is one of the more sensible ways to use kojic acid, since combining brighteners that hit the same enzyme through slightly different routes can be more effective than either alone. Kojic acid is very often formulated alongside other brighteners — arbutin, niacinamide, vitamin C — precisely because it tends to perform best within a combination rather than as a standalone. If you're layering separate products rather than using a pre-formulated serum, introduce them one at a time to check tolerance, keep any kojic acid product in opaque, air-tight packaging (it degrades with light and air), and wear daily sunscreen, which matters more than either active for pigmentation.

Why is kojic acid restricted in the EU? The EU capped kojic acid at a maximum of 1% in leave-on face and hand products under Regulation 2024/996 — the same regulatory package that limited retinol. This followed a safety review (kojic acid had earlier been flagged over animal-study thyroid concerns), which concluded 1% is safe for consumers. The practical consequence for results is important: most of kojic acid's efficacy evidence comes from studies using 2–4%, so an EU-compliant product at 1% is deliberately milder than what the reputation-building studies tested. It's still a legitimate ingredient at the compliant strength, but this cap is part of why its real-world grade sits lower than its lab mechanism might suggest.

Is kojic acid or arbutin better for sensitive skin? Arbutin, without much contest. It's one of the gentlest brighteners available, stable and low-irritation, and suits sensitive and reactive skin well. Kojic acid is the opposite end of the gentle-brightener range: it's the one most linked to allergic contact dermatitis and is photosensitising, so it's more likely to cause problems on reactive skin. For sensitive skin specifically, arbutin (often alongside soothing, well-tolerated partners like niacinamide) is the more comfortable and lower-risk route to a more even-looking tone. As always, patch-test any new product and build up slowly.

The full registry entries for the two actives compared here: alpha-arbutin and kojic acid. See also the sibling comparison arbutin vs hydroquinone.


This is a neutral, educational cosmetic reference from Vallydia, concerning the appearance of skin. It is not medical advice. Persistent or hormonal pigmentation such as melasma is a matter for a dermatologist, and pregnancy use of any pigment active is best discussed with your doctor.

Related reading: Hyaluronic acid · how we grade.

Disclosure

Vallydia sells its own cosmetic serums, and some ingredients discussed here belong to the same categories as those products. Assessments are drawn from the published evidence by the method we publish, and applied to our own ingredients on the same terms — our copper-peptide serum is graded no more kindly than the peptides it competes with. We disclose the interest so you can weigh it.

Brand and trade names appearing in these articles are the property of their respective owners and are used only to identify the product or ingredient under discussion. Their appearance implies no affiliation with, or endorsement by, the proprietor. Where we judge a claim, we are judging the published evidence for that claim — not making a statement about the company that makes it.

Vallydia

A neutral reference and a lawful-lane shop. Registered in Spain. Information for those who seek it — never promotion.

RegionUnited States
ExploreRegisterThe Register — full indexCategoriesTrust & COAHow we gradeOpen data
ShopCosmetic peptidesJournalQuizzes
TermsPrivacyCookiesReturnsShippingImprint

This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia SL — Registered in Spain.

Kojic Acid vs Arbutin: Same Target, Very Different Ingredients · Vallydia